Atlas Trials

Transcriptional Framework for the Molecular Diagnosis of Response to Immunotherapy in Lung Cancer With Agnostic Potential

Clinical trial NCT06807307 · RECRUITING

Trial details

NCT number
NCT06807307
Sponsor
Regina Elena Cancer Institute
Status
RECRUITING
Study type
OBSERVATIONAL
NSCLC
Start date
2024-06-04
Primary completion
2026-06-04
Enrollment
256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.